Parameters | (-) (n = 43) | Cardiovascular event | ||
---|---|---|---|---|
(+) (n = 38) | p value | |||
Age | 58 ± 17 | 66 ± 15 | 0.037 | 1) |
Male | 36 | 28 | 0.289 | 2) |
NYHA functional class III-IV | 6 | 12 | 0.067 | 2) |
IHD | 10 | 10 | 0.800 | 2) |
Rhythm (Af / pacing) | 10 | 17 | 0.059 | 2) |
BNP (pg/mL) | 580 ± 805 | 965 ± 903 | 0.005 | 3) |
Total bilirubin (mg/dL) | 0.93 ± 0.53 | 1.34 ± 0.98 | 0.018 | 1) |
Uric acid (mg/dL) | 7.08 ± 1.89 | 7.76 ± 3.18 | 0.235 | 1) |
eGFR (mL/min/1.73 m2) | 55.8 ± 18.9 | 44.9 ± 19.8 | 0.015 | 1) |
Hemoglobin (g/dL) | 14.3 ± 2.3 | 13.5 ± 1.9 | 0.081 | 1) |
C-reactive protein (mg/dL) | 1.4 ± 3.0 | 1.5 ± 2.9 | 0.039 | 3) |
LAD (cm) | 3.89 ± 0.66 | 4.43 ± 0.91 | 0.003 | 1) |
IVSTd (cm) | 1.08 ± 0.35 | 0.87 ± 0.24 | 0.004 | 1) |
LVPWTd (cm) | 1.11 ± 0.27 | 1.01 ± 0.21 | 0.070 | 1) |
LVDd (cm) | 6.06 ± 0.79 | 6.22 ± 1.25 | 0.465 | 1) |
LVDs (cm) | 5.28 ± 0.85 | 5.50 ± 1.28 | 0.356 | 1) |
LVEF (%) | 31.4 ± 7.6 | 28.5 ± 7.8 | 0.093 | 1) |
RVOT-FS | 0.38 ± 0.20 | 0.27 ± 0.17 | 0.008 | 1) |
RVFAC (%) | 38 ± 14 | 32 ± 14 | 0.086 | 1) |
TR-PG (mmHg) | 25 ± 14 | 25 ± 9 | 0.978 | 1) |
Beta-blocker | 25 | 29 | 0.102 | 2) |
ACE-I/ARB | 28 | 30 | 0.219 | 2) |
Calcium channel blocker | 11 | 6 | 0.413 | 2) |
Diuretic | 24 | 36 | <0.0001 | 2) |
Aldosterone antagonist | 21 | 25 | 0.177 | 2) |